Literature DB >> 33272948

Impacts of Glycemic Control on Intracranial Plaque in Patients with Type 2 Diabetes Mellitus: A Vessel Wall MRI Study.

S Jiao1, J Huang1, Y Chen2, Y Song1, T Gong2, J Lu3, T Guo1, J Zhang1, C Zhang1, M Chen1.   

Abstract

BACKGROUND AND
PURPOSE: The relationship between glycemic control in patients with type 2 diabetes mellitus and intracranial atherosclerotic plaque features has remained understudied. This study aimed to investigate the association of type 2 diabetes mellitus and glycemic control with the characteristics of intracranial plaques using vessel wall MR imaging.
MATERIALS AND METHODS: In total, 311 patients (217 [69.8%] men; mean age, 63.24 ± 11.44 years) with intracranial atherosclerotic plaques detected on vessel wall MR imaging were enrolled and divided into 3 groups according to type 2 diabetes mellitus and glycemic control statuses: the non-type 2 diabetes mellitus group, the type 2 diabetes mellitus with good glycemic control group, and the type 2 diabetes mellitus with poor glycemic control group. The imaging features of intracranial plaque were analyzed and compared among the groups. The clinical risk factors for atherosclerosis were also analyzed using logistic regression analysis.
RESULTS: The plaque length and thickness were significantly higher in the type 2 diabetes mellitus with poor glycemic control group than in the non-type 2 diabetes mellitus group. The prevalence of strongly enhanced plaques was significantly higher in the type 2 diabetes mellitus with poor glycemic control group than in the non-type 2 diabetes mellitus and type 2 diabetes mellitus with good glycemic control groups (92.9%, 63.4%, and 72.7%, respectively; P < .001). Multivariate logistic regression analysis showed a significant association of poor glycemic control with the plaque length (OR = 1.966; 95% CI, 1.170-3.303; P = .011), plaque thickness (OR = 1.981; 95% CI, 1.174-3.340; P = .010), and strongly enhanced plaque (OR = 5.448; 95% CI, 2.385-12.444; P < .001).
CONCLUSIONS: Poor glycemic control, compared with the history of diabetes, might have a greater impact on the burden and vulnerability of intracranial atherosclerotic plaques.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 33272948      PMCID: PMC7814793          DOI: 10.3174/ajnr.A6878

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

Review 1.  Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings.

Authors:  Alejandra I Christen; Ricardo L Armentano; Adrián Miranda; Sebastián Graf; Daniel B Santana; Yanina Zócalo; Hugo P Baglivo; Ramiro A Sánchez
Journal:  Curr Diabetes Rev       Date:  2010-11

2.  Characteristics of patients with enhancing intracranial atherosclerosis and association between plaque enhancement and recent cerebrovascular ischemic events: a high-resolution magnetic resonance imaging study.

Authors:  Juan Huang; Sheng Jiao; Xihai Zhao; Jintao Zhang; Chen Zhang; Min Chen; Yan Song
Journal:  Acta Radiol       Date:  2019-01-16       Impact factor: 1.990

3.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.

Authors:  Karen S Moulton; Khashayar Vakili; David Zurakowski; Mohsin Soliman; Catherine Butterfield; Erik Sylvin; Kin-Ming Lo; Stephen Gillies; Kashi Javaherian; Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

4.  Studies on the age-related changes occurring in human cerebral arteries.

Authors:  C Velican
Journal:  Atherosclerosis       Date:  1970 May-Jun       Impact factor: 5.162

Review 5.  Morphology, sites and epidemiology of cerebral atherosclerosis.

Authors:  J Moossy
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1966

6.  High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla.

Authors:  Chang-Woo Ryu; Geon-Ho Jahng; Eui-Jong Kim; Woo-Suk Choi; Dal-Mo Yang
Journal:  Cerebrovasc Dis       Date:  2009-03-19       Impact factor: 2.762

7.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.

Authors:  K D O'Brien; T O McDonald; A Chait; M D Allen; C E Alpers
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images.

Authors:  Ye Qiao; Steven R Zeiler; Saeedeh Mirbagheri; Richard Leigh; Victor Urrutia; Robert Wityk; Bruce A Wasserman
Journal:  Radiology       Date:  2014-01-16       Impact factor: 11.105

9.  The impact of glucose control on coronary plaque composition in patients with diabetes mellitus.

Authors:  Dong Ju Yang; Moo-Sik Lee; Wan Ho Kim; Hyun Woong Park; Ki-Hong Kim; Taek-Geun Kwon; Sang-Wook Kim; Charanjit S Rihal; Amir Lerman; Jang-Ho Bae
Journal:  J Invasive Cardiol       Date:  2013-03       Impact factor: 2.022

10.  How hyperglycemia promotes atherosclerosis: molecular mechanisms.

Authors:  Doron Aronson; Elliot J Rayfield
Journal:  Cardiovasc Diabetol       Date:  2002-04-08       Impact factor: 9.951

View more
  1 in total

1.  Salidroside Affects Gut Microbiota Structure in db/db Mice by Affecting Insulin, Blood Glucose and Body Weight.

Authors:  Qin Zhao; Jing Shi; Siyuan Chen; Doudou Hao; Sha Wan; Haomeng Niu; Yongqun Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-29       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.